WMG Financial Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $323K | Buy |
1,738
+48
| +3% | +$8.91K | 0.12% | 118 |
|
2025
Q1 | $354K | Sell |
1,690
-447
| -21% | -$93.7K | 0.15% | 95 |
|
2024
Q4 | $380K | Buy |
2,137
+93
| +5% | +$16.5K | 0.16% | 90 |
|
2024
Q3 | $404K | Buy |
2,044
+7
| +0.3% | +$1.38K | 0.18% | 78 |
|
2024
Q2 | $349K | Buy |
2,037
+427
| +27% | +$73.2K | 0.18% | 81 |
|
2024
Q1 | $293K | Buy |
1,610
+148
| +10% | +$27K | 0.17% | 95 |
|
2023
Q4 | $227K | Sell |
1,462
-400
| -21% | -$62K | 0.15% | 105 |
|
2023
Q3 | $278K | Buy |
1,862
+63
| +4% | +$9.39K | 0.24% | 73 |
|
2023
Q2 | $242K | Buy |
1,799
+215
| +14% | +$29K | 0.18% | 94 |
|
2023
Q1 | $295K | Sell |
1,584
-1,680
| -51% | -$313K | 0.24% | 71 |
|
2022
Q4 | $527K | Buy |
3,264
+21
| +0.6% | +$3.39K | 0.45% | 59 |
|
2022
Q3 | $438K | Buy |
3,243
+129
| +4% | +$17.4K | 0.39% | 67 |
|
2022
Q2 | $478K | Sell |
3,114
-193
| -6% | -$29.6K | 0.41% | 61 |
|
2022
Q1 | $537K | Buy |
3,307
+69
| +2% | +$11.2K | 0.39% | 63 |
|
2021
Q4 | $438K | Buy |
+3,238
| New | +$438K | 0.34% | 75 |
|